Daniel Schneider
Chief Executive Officer at PHOTOCURE ASA
Net worth: 497 808 $ as of 2024-04-29
Daniel Schneider active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PHOTOCURE ASA | Chief Executive Officer | 2018-10-31 | - |
| President | 2018-10-31 | - |
Career history of Daniel Schneider
Former positions of Daniel Schneider
| Companies | Position | Start | End |
|---|---|---|---|
| ABLYNX | Chief Executive Officer | - | - |
Training of Daniel Schneider
| University of Washington | Masters Business Admin |
| St. Louis University | Undergraduate Degree |
Statistics
International
| United States | 3 |
| Norway | 2 |
| Belgium | 2 |
Operational
| Chief Executive Officer | 2 |
| President | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| Private companies | 1 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
- Stock Market
- Insiders
- Daniel Schneider
- Experience